Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Mucolipidosis II and two new types of mucolipidosis. 1977

G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009081 Mucolipidoses A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) Cherry Red Spot Myoclonus Syndrome,Ganglioside Sialidase Deficiency Disease,I-Cell Disease,Lipomucopolysaccharidosis,Mucolipidosis,Myoclonus Cherry Red Spot Syndrome,Pseudo-Hurler Polydystrophy,Sialidosis,Cherry Red Spot-Myoclonus Syndrome,Deficiency Disease, Ganglioside Sialidase,Glycoprotein Neuraminidase Deficiency,Inclusion Cell Disease,Mucolipidosis I,Mucolipidosis II,Mucolipidosis III,Mucolipidosis III Alpha Beta,Mucolipidosis IIIa,Mucolipidosis IV,Mucolipidosis Type 1,Mucolipidosis Type I,Mucolipidosis Type II,Mucolipidosis Type III,Mucolipidosis Type IV,Myoclonus-Cherry Red Spot Syndrome,Psuedo-Hurler Disease,Sialolipidosis,Type I Mucolipidosis,Type II Mucolipidosis,Type III Mucolipidosis,Type IV Mucolipidosis,Deficiencies, Glycoprotein Neuraminidase,Deficiency, Glycoprotein Neuraminidase,Glycoprotein Neuraminidase Deficiencies,I Cell Disease,I-Cell Diseases,Inclusion Cell Diseases,Lipomucopolysaccharidoses,Mucolipidoses, Type I,Mucolipidoses, Type II,Mucolipidoses, Type III,Mucolipidoses, Type IV,Mucolipidosis, Type I,Mucolipidosis, Type II,Mucolipidosis, Type III,Mucolipidosis, Type IV,Polydystrophy, Pseudo-Hurler,Pseudo Hurler Polydystrophy,Psuedo Hurler Disease,Psuedo-Hurler Diseases,Sialidoses,Sialolipidoses,Type I Mucolipidoses,Type II Mucolipidoses,Type III Mucolipidoses,Type IV Mucolipidoses
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
February 1976, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
September 1976, Biochimica et biophysica acta,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
June 1978, European journal of biochemistry,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
May 1983, European journal of biochemistry,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
April 1984, European journal of biochemistry,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
July 1977, FEBS letters,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
January 1980, Advances in experimental medicine and biology,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
June 2004, Clinica chimica acta; international journal of clinical chemistry,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
June 1979, European journal of biochemistry,
G Strecker, and M C Peers, and J C Michalski, and T Hondi-Assah, and B Fournet, and G Spik, and J Montreuil, and J P Farriaux, and P Maroteaux, and P Durand
January 1987, Methods in enzymology,
Copied contents to your clipboard!